Andrey Purushottam

Okay. I have two questions. One is, could you comment on the valuation parameters in acquiring these two hospitals, they are at two different EBITDA multiples. Are they meant to be ROCE accretive? Or what is the philosophy in -- financial philosophy apart from growth, obviously? That is my first question.

For the next 12 months.

Right. And do you see a drag on profitability?